Marc Chioda
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Neutropenia and Cancer Infections
Most-Cited Works
- → Clinical Management of Adverse Events Associated with Lorlatinib(2019)159 cited
- → Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity(2012)62 cited
- → Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners(2020)51 cited
- → Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality(2011)44 cited
- → Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain(2014)41 cited
- → The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization(2012)38 cited
- → Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase(2013)36 cited
- → Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations(2015)30 cited
- → Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study.(2020)28 cited
- → A facile, microwave-assisted, palladium-catalyzed arylation of acetone(2007)25 cited